The MarketWatch News Department was not involved in the creation of this content. AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May 19, ...

The Company recently expanded its global footprint through the establishment of a Center of Excellence in Guangdong Province, China. The hub is expected to accelerate product development and ...

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today announced a strategic collaboration with Microsize and Micromacinazione, pioneers in pharmaceutical ...

Nottingham-based Quotient Sciences has launched what it believes is the world’s first clinical trial of a drug formulation ...

Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

Dr. Christine Allen, Co-Founder and CEO of Intrepid Labs, and Dr. Andrew Lewis, Chief Scientific Officer of Quotient Sciences, explain how AI can be used in drug development to shorten development ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has entered into an exclusive ...